Skip to content
Alentis TherapeuticsAlentis Therapeutics
  • We are Alentis
    • About Alentis Therapeutics
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  • Our Science
    • Pipeline
    • ADCs – ALE.P02 & ALE.P03
    • Fibrosis – Lixudebart (ALE.F02)
    • Publications
  • News
    • Press Releases
    • Videos
  • Careers
  • Toggle website search
Press Escape to close the search panel.
Menu Close

Alentis Therapeutics Names Roberto Iacone CEO

  • Post published: July 29, 2020
Continue ReadingAlentis Therapeutics Names Roberto Iacone CEO

ALENTIS Therapeutics launches

  • Post published: April 30, 2019
Continue ReadingALENTIS Therapeutics launches

End of content

No more pages to load

← Newer Posts

Alentis Therapeutics AG

Hegenheimermattweg 167A
4123 Allschwil
Switzerland

Contact:

info@alentis.ch

Statements:

Expanded Access Policy
Cookie Statement
Privacy Statement

Want to know more?
Check our socials

Linkedin Youtube
Close Menu
  • We are Alentis
    • About Alentis Therapeutics
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  • Our Science
    • Pipeline
    • ADCs – ALE.P02 & ALE.P03
    • Fibrosis – Lixudebart (ALE.F02)
  • News
    • Press Releases and News
    • Videos
  • Careers
×

Sign up for our News Notifications

Subscribe to get email notifications when Alentis releases news.

Contact

You’re more than welcome to contact us. Just fill out the form bellow. And we’ll get back tou you as soon as possible.

[contact-form-7 id=”91″ title=”Contact form”]